Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: ACS Infect Dis. 2016 Nov 2;3(1):89–98. doi: 10.1021/acsinfecdis.6b00167

Table 2.

Minimal Inhibitory Concentrations and Potentiating Activities of NSC 60339 and NSC 33353 in Gram-Negative Bacteriaa

strain MIC, μM MPC4 NOV, μM MPC4 ERY, μM MPC4 LEVO, μM




60339 33353 60339 33353 60339 33353 60339 33353
E. coli BW25113 >200 200 100 25 50 25 50 50
P. aeruginosa PAO1 >100 >100 >100 >100 >100 >100 >100 >100
A. baumannii ATCC 17798 >100 >100 >100 6.25 >100 50 >100 >100
E. cloacae ATCC 13047 >100 >100 >100 25 >100 25 >100 >100
K. pneumoniae ATCC 13883 >100 >100 >100 12.5 >100 12.5 >100 25
a

NOV, novobiocin; ERY, erythromycin, LEVO, levofloxacin.